The Global Age-Related Macular Degeneration Market reached US$ 13.10 billion in 2023 and is expected to reach US$ 20.60 billion by 2031, growing at a CAGR of 5.82% during the forecast period 2024-2031. 

Age Related Macular Degeneration Market analysis, according to DataM Intelligence, offers more than just an overview, it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.

The  Age Related Macular Degeneration market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter’s Five Forces Analysis.

Age-related macular degeneration (AMD) is a progressive eye condition that affects the macula, the central part of the retina responsible for sharp, detailed vision. It is a leading cause of vision loss in older adults, typically occurring after age 50. AMD is categorized into two types: dry AMD, characterized by the thinning of the macula, and wet AMD, caused by abnormal blood vessel growth under the retina. While there is no cure, early detection and treatment can slow its progression and help preserve vision.

Forecast Growth Projected:

List of the Key Players in the  Age Related Macular Degeneration Market:

 F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Novartis AG, Apellis Pharmaceuticals, Inc., Astellas Pharma Inc., Biocon, Samsung Bioepis., Bausch + Lomb., Alcon Inc., Nature Made.

Segment Covered in the  Age Related Macular Degeneration Market:

By Type: Dry AMD, Wet AMD.

By Treatment: Anti-VEGF Drugs, AREDS2 Supplements, Photodynamic Therapy, Others.

By Patient Type: Male, Female.

Industry Development:

In October 2024, Ocular Therapeutix, Inc. announced updated timelines for the SOL-1 Phase 3 registrational clinical trial of AXPAXLI for wet age-related macular degeneration (wet AMD). The company now anticipates completing patient enrollment and randomization for the SOL-1 study by the end of 2024, significantly ahead of its earlier projection of the first quarter of 2025. As a result, topline data from the trial are now expected in the fourth quarter of 2025.

Regional Break out:

The global Age Related Macular Degeneration Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Age Related Macular Degeneration manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Age Related Macular Degeneration in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Age Related Macular Degeneration market?

➠ Who are the global key manufacturers of the Age Related Macular Degeneration Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Age Related Macular Degeneration market opportunities and threats faced by the vendors in the global Age Related Macular Degeneration Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Age Related Macular Degeneration market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.